4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3,4:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid salt crystal forms | Patent Number RE048825

US RE048825 E1
Application Number16294607
Publication Number-
Pendency2 years, 8 months, 23 days
Filled DateMar 6, 2019
Priority DateMar 12, 2008
Publication Date-
Expiration DateMar 11, 2028
Inventor/ApplicantsJohn Tomesch
Lawrence P. Wennogle
ExaminesJONES, DWAYNE C
Art Unit3991
Technology Center3900
Assignments
Intracellular Therapies Inc.
Current
Intracellular Therapies Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.